Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Bayer Announces 2016 BHAP Recipients
Bayer Announces 2016 BHAP Recipients
Industry
Novo Presents Initial Results of B-HERO-S Study
Novo Presents Initial Results of B-HERO-S Study
Industry
BioMarin Reports Continued Progress in Clinical Trial for Hemophilia A Gene Therapy
Spark Announces New Data on Its FIX Gene Therapy
Industry
UniQure Escalates Hemophilia B Gene Therapy Manufacturing Site
UniQure’s Gene Therapy Performing well in Hemophilia B Trial
Industry
Shire/Baxalta Complete $32 Billion Merger
Shire/Baxalta Complete $32 Billion Merger
Industry
ACE910 Shows Positive Efficacy and Safety Data in Phase I Trial
ACE910 Shows Positive Efficacy and Safety Data in Phase I Trial
Industry
Sangamo Reports Early Progress in Pre-Clinical Hemophilia A Gene Therapy Studies
Sangamo Reports Early Progress in Pre-Clinical Hemophilia A Gene…
Industry
Preliminary Data Show Progress for BioMarin’s Factor VIII Gene Therapy
Preliminary Data Show Progress for BioMarin’s Factor VIII Gene Therapy
Industry
FDA Accepts License Application and Grants Priority Review for Emicizumab
FDA Approves Generic Version of Tranexamic Acid
Industry
Pfizer and King’s College of London to Develop Gene Therapy Technologies
Pfizer and King’s College of London to Develop Gene Therapy Technologies
Industry
Alnylam Announces Extension of Study for ALN-AT3
Alnylam Announces Extension of Study for ALN-AT3
Industry
Sangamo and Pfizer Announce Interim Gene Therapy Findings
Patient Enrollment Begins for Biomarin’s Investigational Hemophilia…
Industry
FDA Grants Breakthrough Status to Genentech’s Investigational Therapy for Hemophilia A
FDA Grants Breakthrough Status to Genentech’s Investigational…
Industry
Octapharma Announces Expanded Approval for Wilate®
FDA Approves Emergent’s New rFIX Therapy
Industry
Novo Nordisk Announces Launch of Novoeight®
Novo Nordisk Announces Launch of Novoeight®